Po-hsin C. Lee

No. 1650, Sect. 4, Taiwan Boulevard, 407
Taitung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Afatinib Versus Osimertinib as First-Line Treatment for Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A 3-Year Follow-Up Overall Survival Analysis.

Afatinib Versus Osimertinib as First-Line Treatment for Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A 3-Year Follow-Up Overall Survival Analysis.

Journal: Targeted oncology

Published: March 06, 2026

The Importance of Driver-Targeted Therapy Among Patients With Lung Cancer Initially Diagnosed in the Intensive Care Unit.

The Importance of Driver-Targeted Therapy Among Patients With Lung Cancer Initially Diagnosed in the Intensive Care Unit.

Journal: Asia-Pacific journal of clinical oncology

Published: January 02, 2026

Study of benign prostatic hyperplasia and androgen pathway manipulation on lung cancer survivals.

Study of benign prostatic hyperplasia and androgen pathway manipulation on lung cancer survivals.

Journal: Journal of advanced research

Published: November 10, 2025

Applying next-generation sequencing to predict short progression-free survival in patients with advanced EGFR -mutant lung adenocarcinoma receiving epidermal growth factor receptor tyrosine kinase inhibitors.

Applying next-generation sequencing to predict short progression-free survival in patients with advanced EGFR -mutant lung adenocarcinoma receiving epidermal growth factor receptor tyrosine kinase inhibitors.

Journal: Anti-cancer drugs

Published: July 20, 2025

Lauryl gallate induces apoptosis via p38-MAPK phosphorylation and autophagy in chemoresistant human lung cancer cells.

Lauryl gallate induces apoptosis via p38-MAPK phosphorylation and autophagy in chemoresistant human lung cancer cells.

Journal: Archives of biochemistry and biophysics

Published: June 12, 2025

Survival Outcomes in Lung Cancer Patients Newly Diagnosed Through Brain Metastasis Surgery: Impact of Druggable Mutations and Radiotherapy.

Survival Outcomes in Lung Cancer Patients Newly Diagnosed Through Brain Metastasis Surgery: Impact of Druggable Mutations and Radiotherapy.

Journal: OncoTargets and therapy

Published: February 04, 2025

Osimertinib as Second- and ≥Third-Line Treatment in Advanced and Recurrence EGFR-Mutant NSCLC Patients Harboring Acquired T790M Mutation.

Osimertinib as Second- and ≥Third-Line Treatment in Advanced and Recurrence EGFR-Mutant NSCLC Patients Harboring Acquired T790M Mutation.

Journal: Cancers

Published: November 07, 2024

Using a Polygenic Risk Score to Improve the Risk Prediction of Non-Small Cell Lung Cancer in Taiwan.

Using a Polygenic Risk Score to Improve the Risk Prediction of Non-Small Cell Lung Cancer in Taiwan.

Journal: JCO precision oncology

Published: September 30, 2024

Benefits of NGS in Advanced Lung Adenocarcinoma Vary by Populations and Timing of Examination.

Benefits of NGS in Advanced Lung Adenocarcinoma Vary by Populations and Timing of Examination.

Journal: International journal of molecular sciences

Published: May 24, 2024

Real-world clinical efficacy of bevacizumab biosimilar in patients with advanced non-small-cell lung cancer.

Real-world clinical efficacy of bevacizumab biosimilar in patients with advanced non-small-cell lung cancer.

Journal: Therapeutic advances in medical oncology

Published: May 23, 2024

Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma.

Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma.

Journal: Frontiers in oncology

Published: November 12, 2022

Diagnosis of Legionnaires' Disease Assisted by Next-Generation Sequencing in a Patient with COVID-19.

Diagnosis of Legionnaires' Disease Assisted by Next-Generation Sequencing in a Patient with COVID-19.

Journal: Infection and drug resistance

Published: November 05, 2022

Showing 1-12 of 25

Last Updated: 09/26/2026